Deutsche Bank
LYRA

Deutsche Bank’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Deutsche Bank’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,527
Closed -$697K – 4339
2021
Q3 		$697K Sell
1,527
-2
-0.1% -$756 ﹤0.01% 2842
2021
Q2 		$614K Sell
1,529
-87
-5% -$39.6K ﹤0.01% 3084
2021
Q1 		$936K Buy
1,616
+1,521
+1,601% +$950K ﹤0.01% 2708
2020
Q4 		$54K Buy
95
+53
+126% +$29.9K ﹤0.01% 4097
2020
Q3 		$23K Buy
42
+4
+11% +$2.49K ﹤0.01% 4095
2020
Q2 		$21K Buy
+38
New +$27.8K ﹤0.01% 4038

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Deutsche Bank's LYRA Position: Q4 2021 in Review

Deutsche Bank sold out of LYRA THERAPEUTICS INC (LYRA) in Q4 2021, closing a stake of 1,527 shares — an estimated $697K sold.

Deutsche Bank first reported a position in LYRA in Q2 2020 and held it in 6 quarters. The position peaked at $936K in Q1 2021. 33 funds tracked by Wall St. Rank hold LYRA as of Q4 2021.

  • Deutsche Bank reported no remaining LYRA THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • Deutsche Bank sold 1,527 LYRA THERAPEUTICS INC shares in Q4 2021, an estimated $697K.
  • Deutsche Bank first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 6 quarters.
  • Deutsche Bank's LYRA THERAPEUTICS INC position peaked at $936K in Q1 2021.
  • 33 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q4 2021.

Based on Deutsche Bank's 13F filing for Q4 2021, filed 11 Feb 2022.